{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:32:31Z","timestamp":1793377951478,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109032","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:43:47Z","timestamp":1783665827000},"page":"109032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Changes in peripheral blood leukocyte profiles during elexacaftor\/tezacaftor\/ivacaftor therapy in cystic fibrosis according to baseline lung function"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0526-7169","authenticated-orcid":false,"given":"\u0141ukasz","family":"Pyzia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Francuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Pyzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rachel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2026.109032_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/pir.2019-0212","article-title":"Cystic fibrosis","volume":"42","author":"Dickinson","year":"2021","journal-title":"Pediatr. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2026.109032_bib2","first-page":"584","article-title":"Cystic fibrosis: current concepts","volume":"78","author":"L\u00f3pez-Valdez","year":"2021","journal-title":"Bol. Med. Hosp. Infant. Mex."},{"issue":"1","key":"10.1016\/j.rmed.2026.109032_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1891\/NN-2022-0007","article-title":"Cystic fibrosis: back to the basics","volume":"42","author":"Myer","year":"2023","journal-title":"Neonatal Netw"},{"issue":"8","key":"10.1016\/j.rmed.2026.109032_bib4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/ppul.24823","article-title":"Clinical characteristics of rare CFTR mutations causing cystic fibrosis in Polish population","volume":"55","author":"Zybert","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"8","key":"10.1016\/j.rmed.2026.109032_bib5","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2213-2600(16)30188-6","article-title":"Classification of CFTR mutation classes","volume":"4","author":"Marson","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109032_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/arm92040026","article-title":"Cystic fibrosis: understanding cystic fibrosis transmembrane regulator mutation classification and modulator therapies","volume":"92","author":"Anwar","year":"2024","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.rmed.2026.109032_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ejim.2014.09.018","article-title":"Cystic fibrosis\u2014what are the prospects for a cure?","volume":"25","author":"Kumar","year":"2014","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109032_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1165\/rcmb.2019-0239ED","article-title":"Airway surface liquid and impaired antiviral defense in cystic fibrosis","volume":"62","author":"Voynow","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109032_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4187\/respcare.06697","article-title":"Cystic fibrosis lung disease: an overview","volume":"65","author":"Turcios","year":"2020","journal-title":"Respir. Care"},{"key":"10.1016\/j.rmed.2026.109032_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulm. Med."},{"issue":"174","key":"10.1016\/j.rmed.2026.109032_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0068-2024","article-title":"Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy","volume":"33","author":"Milczewska","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.109032_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00431-024-05905-9","article-title":"Antibiotic treatment of bacterial lung infections in cystic fibrosis","volume":"184","author":"Taccetti","year":"2025","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.rmed.2026.109032_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells10123380","article-title":"Revisiting the role of leukocytes in cystic fibrosis","volume":"10","author":"Averna","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.rmed.2026.109032_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1180282","article-title":"Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor\u2013Tezacaftor\u2013Ivacaftor treatment","volume":"14","author":"Schmidt","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109032_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1099-0496(199708)24:2<137::AID-PPUL13>3.0.CO;2-3","article-title":"Current understanding of the inflammatory process in cystic fibrosis: onset and etiology","volume":"24","author":"Konstan","year":"1997","journal-title":"Pediatr. Pulmonol."},{"issue":"6","key":"10.1016\/j.rmed.2026.109032_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2015-0271","article-title":"Neutrophils in cystic fibrosis","volume":"397","author":"Laval","year":"2016","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.rmed.2026.109032_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1165\/rcmb.2019-0107ED","article-title":"Cystic fibrosis inflammation: hyperinflammatory, hypoinflammatory, or both?","volume":"61","author":"Murphy","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.rmed.2026.109032_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jped.2013.02.007","article-title":"The impact of cystic fibrosis on the immunologic profile of pediatric patients","volume":"89","author":"Bernardi","year":"2013","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.rmed.2026.109032_bib19","first-page":"548","article-title":"Review of rapid advances in cystic fibrosis","volume":"117","author":"Link","year":"2020","journal-title":"Mo. Med."},{"issue":"11","key":"10.1016\/j.rmed.2026.109032_bib20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S2213-2600(24)00208-X","article-title":"The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study","volume":"12","author":"Burgel","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.109032_bib21","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF registry","volume":"32","author":"Sutharsan","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.rmed.2026.109032_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2022","article-title":"Elexacaftor\/tezacaftor\/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis","volume":"61","author":"Cavinato","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109032_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02096-2022","article-title":"Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis","volume":"61","author":"Dhote","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109032_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-77246-4","article-title":"One year of ETI reduces lung bacterial colonisation in adults with cystic fibrosis","volume":"14","author":"Mianowski","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.rmed.2026.109032_bib25","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/crj.12920","article-title":"Is an FEV1 of 80% predicted a normal spirometry in cystic fibrosis children and adults?","volume":"12","author":"K\u00f6nig","year":"2018","journal-title":"Clin. Res. J"},{"issue":"suppl 63","key":"10.1016\/j.rmed.2026.109032_bib26","article-title":"Adult Cystic Fibrosis (CF) patients prefer to perform impulse oscillometry (IOS) in comparison to spirometry","volume":"54","author":"Lee","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109032_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.692949","article-title":"What is Most suitable for children with cystic fibrosis\u2014the relationship between spirometry, oscillometry, and multiple breath nitrogen washout","volume":"9","author":"Postek","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.rmed.2026.109032_bib28","doi-asserted-by":"crossref","unstructured":"de Aquino CSB, Rodrigues JC, da Silva-Filho LVRF. Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV1 decline. J. Bras. Pneumol. 48(3):e20210237. doi:10.36416\/1806-3756\/e20210237.","DOI":"10.36416\/1806-3756\/e20210237"},{"issue":"6","key":"10.1016\/j.rmed.2026.109032_bib29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0039-1697975","article-title":"Acute pulmonary exacerbations in cystic fibrosis","volume":"40","author":"Goss","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.109032_bib30","first-page":"1898","article-title":"Inflammation and infection in cystic fibrosis: update for the clinician","volume":"9","author":"Petrocheilou","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.rmed.2026.109032_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-016-0489-2","article-title":"End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis","volume":"18","author":"Lammertyn","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2026.109032_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14017","article-title":"A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis","volume":"8","author":"Moretti","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:36:11Z","timestamp":1793374571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S0954611126004002"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109032","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in peripheral blood leukocyte profiles during elexacaftor\/tezacaftor\/ivacaftor therapy in cystic fibrosis according to baseline lung function","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109032"}}